← Back to Clinical Trials
Recruiting NCT07338955

NCT07338955 Validating and Assessing Reliability

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07338955
Status Recruiting
Phase
Sponsor Bahria University
Condition Upper Limb Disability
Study Type OBSERVATIONAL
Enrollment 385 participants
Start Date 2025-11-03
Primary Completion 2025-12-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type OBSERVATIONAL
Interventions
All participants (Aviane)data collection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 385 participants in total. It began in 2025-11-03 with a primary completion date of 2025-12-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.

Eligibility Criteria

Inclusion Criteria: Diagnosed with any upper limb disability or deformity . Able to read, understand and speak Urdu. Individuals with symptoms enduring for at least one week . Exclusion Criteria: Cognitive impairment or psychiatric illness that hinders understanding of the questionnaire. Patients with congenital deformities. Refusal to give informed consent.

Contact & Investigator

Central Contact

Rabia Khan, Masters in Physiotherapy

✉ iamrabiakhan@gmail.com

📞 +923452310047

Frequently Asked Questions

Who can join the NCT07338955 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Upper Limb Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07338955 currently recruiting?

Yes, NCT07338955 is actively recruiting participants. Contact the research team at iamrabiakhan@gmail.com for enrollment information.

Where is the NCT07338955 trial being conducted?

This trial is being conducted at Karachi, Pakistan.

Who is sponsoring the NCT07338955 clinical trial?

NCT07338955 is sponsored by Bahria University. The trial plans to enroll 385 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology